Have you had the chance to play around on ChatGPT, the open AI? It can “talk” to you in text kind of like a person.
I have tried it out.
It’s quite interesting to type in scientific questions and see what pops out. Often it is high-quality text and solid ideas, but not always. You can also ask it philosophical questions. ChatGPT will even write pages of text for you if you ask. Naturally, there are concerns about people misusing this resource. For instance, students could have the AI write their homework essays for them.
In science, researchers could try to have ChatGPT write papers for them. How serious is this? Nature editorialized (below) on the threat it sees.
Tools such as ChatGPT threaten transparent science; here are our ground rules for their use, Nature. This editorial begins to consider the complexities posed by this open AI. Other AI might be able to create fake data figures. We’re in a hairy period where it’s not clear how such AI tools will disrupt research publishing. You can already find articles on PubMed that list ChatGPT as an author.
Apparently Google also sees ChatGPT as a threat to its near monopoly on internet search. I can see why. If something like Chat GPT would also be plugged into the web, it may deliver a much more pleasant and potentially more useful output to searches.
- Publisher investigating “serious concerns” about article on ivermectin, COVID, and the microbiome, Retraction Watch. The story is about a paper in Frontiers of Microbiology whose sole author is Dr. Sabine Hazan. Retraction Watch also pointed out that about a year ago the FDA sent Hazan a warning letter as leader of the firm Topelia Therapeutics. The letter notes “objectional conditions.”
- I Edited Human DNA at Home With a DIY CRISPR Kit, MOTHERBOARD. This is from biohacker Jo Zayner. David Ishii may have a role too based on a tweet. I believe the kits used to be for editing only microbe DNA but the human cell part is newer. Are there meaningful risks here? Getting people excited about gene editing and science is definitely a plus.
- Lab-grown eye cells form new neural connections, NIH.
- Going on Trial: Arbaclofen reboot; cell implants; psilocybin microdoses, Spectrum.
- Dr. Vito Imbasciani elected as Chair of California stem cell agency, CIRM.
Stem cell organoids could one day help treat kidney disease, Cosmos Magazine.